139 related articles for article (PubMed ID: 6589167)
1. A monoclonal antibody to myelogenous leukemia: isolation and characterization.
Malcolm AJ; Shipman RC; Logan PM; Levy JG
Exp Hematol; 1984 Aug; 12(7):539-47. PubMed ID: 6589167
[TBL] [Abstract][Full Text] [Related]
2. Detection of a common leukemia-associated antigen in human myelogenous leukemia using immunoperoxidase.
Logan PM; Malcolm AJ; Levy JG
Diagn Immunol; 1984; 2(2):86-100. PubMed ID: 6238754
[TBL] [Abstract][Full Text] [Related]
3. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
Andreasen RB; Olsson L
J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
[TBL] [Abstract][Full Text] [Related]
4. Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL).
Shellard JE; Leitch HA; Logan PM; McMaster WR; Levy JG
Exp Hematol; 1991 Feb; 19(2):136-42. PubMed ID: 1991495
[TBL] [Abstract][Full Text] [Related]
5. Detection of a tumor-associated antigen on the surface of human myelogenous leukemia cells.
Malcolm AJ; Shipman RC; Levy JG
J Immunol; 1982 Jun; 128(6):2599-603. PubMed ID: 7042842
[TBL] [Abstract][Full Text] [Related]
6. Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cell lines subsequent to light activation.
Mew D; Lum V; Wat CK; Towers GH; Sun CH; Walter RJ; Wright W; Berns MW; Levy JG
Cancer Res; 1985 Sep; 45(9):4380-6. PubMed ID: 4028022
[TBL] [Abstract][Full Text] [Related]
7. Specificity of heteroantisera to human acute leukemia-associated antigens.
Baker MA; Ramachandar K; Taub RN
J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody against myeloid leukemia cell line (KG-1).
Aota F; Chang D; Hill NO; Khan A
Cancer Res; 1983 Mar; 43(3):1093-6. PubMed ID: 6572095
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody against a unique antigen on human acute promyelocytic leukemia cell line (HL-60).
Aota F; Chang D; Hill NO; Khan A
Exp Hematol; 1982 Nov; 10(10):835-43. PubMed ID: 6759147
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of monoclonal anti-K 562 antibodies with cells of leukemia- and lymphoma-patients.
Hering S; Böttger V; Baryschnikow AJ; Micheel B
Arch Geschwulstforsch; 1985; 55(1):9-16. PubMed ID: 3885896
[TBL] [Abstract][Full Text] [Related]
11. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
Ball ED; Kadushin JM; Schacter B; Fanger MW
J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
[TBL] [Abstract][Full Text] [Related]
12. Juvenile chronic myelogenous leukemia: surface antigen phenotyping by monoclonal antibodies and cytogenetic studies.
Shannon K; Nunez G; Dow LW; Weinberg AG; Sato Y; Stastny P; Buchanan GR
Pediatrics; 1986 Mar; 77(3):330-5. PubMed ID: 3513115
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody detecting a 39,000 m.w. molecule that is present on B lymphocytes and chronic lymphocytic leukemia cells but is rare on acute lymphocytic leukemia blasts.
Zipf TF; Lauzon GJ; Longenecker BM
J Immunol; 1983 Dec; 131(6):3064-72. PubMed ID: 6358359
[TBL] [Abstract][Full Text] [Related]
14. Detection of terminal transferase in acute myeloid leukemia by flow cytometry.
Paietta E; Meenan B; Heavey C; Thomas D
Cytometry; 1994 Jul; 16(3):256-61. PubMed ID: 7924695
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
[TBL] [Abstract][Full Text] [Related]
16. P53 protein expression in human leukemia and lymphoma cells.
Koníková E; Kusenda J
Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
[TBL] [Abstract][Full Text] [Related]
17. Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia.
Hofmann M; Große-Hovest L; Nübling T; Pyż E; Bamberg ML; Aulwurm S; Bühring HJ; Schwartz K; Haen SP; Schilbach K; Rammensee HG; Salih HR; Jung G
Leukemia; 2012 Jun; 26(6):1228-37. PubMed ID: 22289926
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human myelogenous leukemia cells in the fluorescence-activated cell sorter using a tumor-specific antiserum.
Malcolm AJ; Logan PM; Shipman RC; Kurth R; Levy JG
Blood; 1983 May; 61(5):858-66. PubMed ID: 6338975
[TBL] [Abstract][Full Text] [Related]
19. Human monoclonal antibodies to human leukemias. Initial characterization of specificities and antigens.
Posner MR; Santos DJ; Elboim HS; Frackelton AR
Prog Clin Biol Res; 1989; 288():95-9. PubMed ID: 2717644
[No Abstract] [Full Text] [Related]
20. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
